Filing Details
- Accession Number:
- 0001567619-20-013325
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-15 21:32:23
- Reporting Period:
- 2020-04-30
- Accepted Time:
- 2020-07-15 21:32:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197355 | J Henry Fuchs | C/O Biomarin Pharmaceutical Inc. 770 Lindaro St. San Rafael CA 94901 | President, Worldwide R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-04-30 | 339 | $62.59 | 102,995 | No | 5 | A | Direct | |
| Common Stock | Acquisiton | 2020-07-13 | 224 | $67.81 | 103,219 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-07-13 | 13,810 | $67.81 | 117,029 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-07-13 | 8,977 | $63.10 | 126,006 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-13 | 23,011 | $130.00 | 102,995 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to buy Common Stock) | Disposition | 2020-07-13 | 224 | $0.00 | 224 | $67.81 |
| Common Stock | Stock Option (Right to buy Common Stock) | Disposition | 2020-07-13 | 13,810 | $0.00 | 13,810 | $67.81 |
| Common Stock | Stock Option (Right to buy Common Stock) | Disposition | 2020-07-13 | 8,977 | $0.00 | 8,977 | $63.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,250 | 2017-01-15 | 2023-05-14 | No | 4 | M | Direct |
| 75,716 | 2013-11-15 | 2023-05-14 | No | 4 | M | Direct |
| 49,423 | 2014-12-04 | 2024-06-03 | No | 4 | M | Direct |
Footnotes
- Represents shares acquired by the reporting person on April 30, 2020, pursuant to the issuer's Employee Stock Purchase Plan.
- Trade made pursuant to a 10b5-1 plan executed on March 11, 2020.
- The price in column 4 is the weighted average price. The price actually received ranged from $130.00 to $130.025. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
- Reflects the number of options outstanding after the transactions from this specific stock option grant.
Billionaire Hedge Funds
